Evidence map›Paper›PMID 25035309›Full record

ReviewBMJ (Clinical research ed.)2014

Non-cardiovascular effects associated with statins.

Chintan S Desai, Seth S Martin, Roger S Blumenthal

Registry-linked trialAbstract readReview
In one paragraph

Review in BMJ (Clinical research ed.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02341664 (Patient and Provider Assessment of Lipid Management Registry), which is not on this map. Cited by 61 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 6 pooled it
30.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02341664 completednot on this mapstarted 2015, after this paper: background citation

Patient and Provider Assessment of Lipid Management Registry

Typeobservational_patient_registrySponsorDuke UniversityRan2015 to 2016Enrolled7,658ConditionsHyperlipidemia, Hypercholesterolemia, Cardiovascular Disease, Diabetes
3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 6 syntheses or guidelines pooled it, 171 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Impact on cognitive function-are all statins the same?Current atherosclerosis reports · 2015
    Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Lovastatin for the Treatment of Adult Patients With Dengue: A Randomized, Double-Blind, Placebo-Controlled Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Trial
  11. Trial
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Chintan S DesaiJohns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD 21287, USA cdesai6@jhmi.edu.
Seth S MartinJohns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD 21287, USA.
Roger S BlumenthalJohns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD 21287, USA.
Johns Hopkins University · US

Funding

CARDIOVASCULAR EPIDEMIOLOGY INSTITUTIONAL TRAININGT32HL007024 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Elizabeth Selvin · 1985 to 2026
$17.5M
NHLBI NIH HHS T32HL07024
6 · The paper itself

Abstract

Statins form the pharmacologic cornerstone of the primary and secondary prevention of atherosclerotic cardiovascular disease. In addition to beneficial cardiovascular effects, statins seem to have multiple non-cardiovascular effects. Although early concerns about statin induced hepatotoxicity and cancer have subsided owing to reassuring evidence, two of the most common concerns that clinicians have are myopathy and diabetes. Randomized controlled trials suggest that statins are associated with a modest increase in the risk of myositis but not the risk of myalgia. Severe myopathy (rhabdomyolysis) is rare and often linked to a statin regimen that is no longer recommended (simvastatin 80 mg). Randomized controlled trials and meta-analyses suggest an increase in the risk of diabetes with statins, particularly with higher intensity regimens in people with two or more components of the metabolic syndrome. Other non-cardiovascular effects covered in this review are contrast induced nephropathy, cognition, cataracts, erectile dysfunction, and venous thromboembolism. Currently, systematic reviews and clinical practice guidelines indicate that the cardiovascular benefits of statins generally outweigh non-cardiovascular harms in patients above a certain threshold of cardiovascular risk. Literature is also accumulating on the potential non-cardiovascular benefits of statins, which could lead to novel applications of this class of drug in the future.

Indexed as

Acute Kidney InjuryCataractChemical and Drug Induced Liver InjuryClinical Trials as TopicCognitionContrast MediaDementiaDiabetes MellitusErectile DysfunctionFatigueGenetic Predisposition to DiseaseHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHypercholesterolemiaKidney DiseasesLiverContrast MediaHydroxymethylglutaryl-CoA Reductase InhibitorsLiver-Specific Organic Anion Transporter 1Organic Anion TransportersSLCO1B1 protein, humanTransaminases

Identifiers

PMID25035309
PMCPMC4707717
OpenAlexW2131124395

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.